We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Emerson Stock Gains From Business Strength, Headwinds Persist
Read MoreHide Full Article
Emerson Electric Co. (EMR - Free Report) is benefiting from solid momentum across the Intelligent Devices and Software and Control segments. Within the Intelligent Devices segment, strength in the Final Control business, driven by solid momentum in power end markets, is driving the company’s performance. Sales from this business increased 4% year over year in the first quarter of fiscal 2025 (ended December 2024).
Robust growth in all geographies and strong backlog conversion levels are aiding the Measurement & Analytical business (sales rose 3% year over year in the fiscal first quarter). Within the Software and Control segment, strength in the power and process end markets is supporting the Control Systems & Software business. Revenues from the business increased 2% year over year in the fiscal first quarter.
Given the strength across its end markets, Emerson has provided a bullish forecast for fiscal 2025 (ending September 2025). The company expects net sales to increase approximately 1.5-3.5% year over year. Underlying sales are anticipated to increase 3-5% in the same period.
Emerson believes in expanding its market presence, solidifying its customer base and enhancing product offerings through acquisitions. In March 2025, it acquired all outstanding shares of Aspen Technology, Inc.’s common stock that it did not own. It is worth noting that EMR acquired a 55% majority stake in AspenTech in 2022, later increasing its ownership to around 57%.
Also, in the fourth quarter of fiscal 2023, the company completed the acquisitions of Afag and Flexim. The buyout of Afag boosted Emerson’s capabilities in factory automation, helping it expand into lucrative end markets, battery manufacturing, automotive, packaging, medical, life sciences and electronics. The acquisition of Flexim expanded its automation portfolio and measurement capabilities. Acquisitions had a positive impact of 9% on underlying sales growth in fiscal 2024.
EMR’s shareholder-friendly policies also add to its appeal. In the first three months of fiscal 2025, it paid out dividends of $301 million and repurchased shares worth $899 million. Also, in November 2024, the company hiked its dividend by 0.5%. Emerson plans to repurchase shares worth $2 billion and pay out dividends of $1.2 billion in fiscal 2025.
EMR’s Price Performance
Image Source: Zacks Investment Research
In the past six months, shares of the Zacks Rank #3 (Hold) company have lost 9% compared with the industry’s 20.1% decline.
Despite the positives, EMR has been witnessing weakness in the Safety & Productivity, Discrete Automation and Test & Measurement businesses of late. The Safety & Productivity business is witnessing weakness owing to tepid demand for its product in the Americas and Europe regions. Sales from the business declined 3% in the first quarter of fiscal 2025.
The Discrete Automation business’ sales declined 5% in the fiscal first quarter due to softness across all geographies. Weakness in the Europe region is adversely affecting the Test & Measurement business’ sales, which declined 6% in the fiscal first quarter.
Emerson is undertaking restructuring measures to improve operational efficiency and increase the asset base worldwide. However, the same poses a threat to its bottom line in the near term. In the fiscal first quarter, restructuring and related costs was $12.9 million.
Stocks to Consider
Some better-ranked companies from the same space are discussed below.
DNOW delivered a trailing four-quarter average earnings surprise of 30.4%. In the past 60 days, the Zacks Consensus Estimate for DNOW’s 2025 earnings has increased 10.3%.
Dover Corporation (DOV - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 5.3%.
In the past 60 days, the consensus estimate for DOV’s 2025 earnings has increased 0.3%.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 5.3%.
The Zacks Consensus Estimate for AIT’s fiscal 2025 (ending June 2025) earnings has improved 0.3% in the past 60 days.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Emerson Stock Gains From Business Strength, Headwinds Persist
Emerson Electric Co. (EMR - Free Report) is benefiting from solid momentum across the Intelligent Devices and Software and Control segments. Within the Intelligent Devices segment, strength in the Final Control business, driven by solid momentum in power end markets, is driving the company’s performance. Sales from this business increased 4% year over year in the first quarter of fiscal 2025 (ended December 2024).
Robust growth in all geographies and strong backlog conversion levels are aiding the Measurement & Analytical business (sales rose 3% year over year in the fiscal first quarter). Within the Software and Control segment, strength in the power and process end markets is supporting the Control Systems & Software business. Revenues from the business increased 2% year over year in the fiscal first quarter.
Given the strength across its end markets, Emerson has provided a bullish forecast for fiscal 2025 (ending September 2025). The company expects net sales to increase approximately 1.5-3.5% year over year. Underlying sales are anticipated to increase 3-5% in the same period.
Emerson believes in expanding its market presence, solidifying its customer base and enhancing product offerings through acquisitions. In March 2025, it acquired all outstanding shares of Aspen Technology, Inc.’s common stock that it did not own. It is worth noting that EMR acquired a 55% majority stake in AspenTech in 2022, later increasing its ownership to around 57%.
Also, in the fourth quarter of fiscal 2023, the company completed the acquisitions of Afag and Flexim. The buyout of Afag boosted Emerson’s capabilities in factory automation, helping it expand into lucrative end markets, battery manufacturing, automotive, packaging, medical, life sciences and electronics. The acquisition of Flexim expanded its automation portfolio and measurement capabilities. Acquisitions had a positive impact of 9% on underlying sales growth in fiscal 2024.
EMR’s shareholder-friendly policies also add to its appeal. In the first three months of fiscal 2025, it paid out dividends of $301 million and repurchased shares worth $899 million. Also, in November 2024, the company hiked its dividend by 0.5%. Emerson plans to repurchase shares worth $2 billion and pay out dividends of $1.2 billion in fiscal 2025.
EMR’s Price Performance
Image Source: Zacks Investment Research
In the past six months, shares of the Zacks Rank #3 (Hold) company have lost 9% compared with the industry’s 20.1% decline.
Despite the positives, EMR has been witnessing weakness in the Safety & Productivity, Discrete Automation and Test & Measurement businesses of late. The Safety & Productivity business is witnessing weakness owing to tepid demand for its product in the Americas and Europe regions. Sales from the business declined 3% in the first quarter of fiscal 2025.
The Discrete Automation business’ sales declined 5% in the fiscal first quarter due to softness across all geographies. Weakness in the Europe region is adversely affecting the Test & Measurement business’ sales, which declined 6% in the fiscal first quarter.
Emerson is undertaking restructuring measures to improve operational efficiency and increase the asset base worldwide. However, the same poses a threat to its bottom line in the near term. In the fiscal first quarter, restructuring and related costs was $12.9 million.
Stocks to Consider
Some better-ranked companies from the same space are discussed below.
DNOW Inc. (DNOW - Free Report) currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
DNOW delivered a trailing four-quarter average earnings surprise of 30.4%. In the past 60 days, the Zacks Consensus Estimate for DNOW’s 2025 earnings has increased 10.3%.
Dover Corporation (DOV - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 5.3%.
In the past 60 days, the consensus estimate for DOV’s 2025 earnings has increased 0.3%.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 5.3%.
The Zacks Consensus Estimate for AIT’s fiscal 2025 (ending June 2025) earnings has improved 0.3% in the past 60 days.